TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,928 | +88.0% | 11,132 | +2.0% | 0.00% | – |
| Q4 2022 | $11,129 | -61.6% | 10,911 | -0.4% | 0.00% | – |
| Q3 2022 | $29,000 | -38.3% | 10,950 | +4.3% | 0.00% | – |
| Q2 2022 | $47,000 | -54.8% | 10,495 | -0.8% | 0.00% | -100.0% |
| Q1 2022 | $104,000 | -39.9% | 10,582 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $173,000 | +154.4% | 11,328 | +125.3% | 0.00% | – |
| Q3 2021 | $68,000 | -6.8% | 5,028 | +0.7% | 0.00% | – |
| Q2 2021 | $73,000 | – | 4,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |